kt-413,kt-333
kymera therapeutics
['kt-333 ', 'kt-413', 'kymera ']
today we shared new clinical trial updates focused on pk/pd and safety from our oncology programs kt-333 and kt-413, and we ll be presenting a poster on the kt-333 data at the this friday. read the full press release here: and check out the 
Advancing the field of targeted protein degradation to deliver breakthrough medicines for previously untreatable diseases